Skip to content

Category: Biotechnology

South Korea’s K-Bio Lab Hub forms MoU with Monash University

By API User

Australia’s biotech capital, Melbourne, has further strengthened its research and development capabilities through a newly formed Memorandum of Understanding (MoU) between Monash University and K-Bio Lab Hub – South Korea’s government-backed biotech incubator. Under the MoU, K-Bio Lab Hub will explore commencing its first Australian launchpad within the Monash Technology Precinct and support biotech startups from … Continued

CUREator+ delivers $15.7 m to local BioMedTech Startups Tackling the Global Dementia Challenge

By API User

Melbourne, Australia – Monday 22 September 2025 – The CUREator + Dementia and Cognitive Decline BioMedTech Incubator today announced seven companies will receive $15,765,871 in non-dilutive funding. With funding from the Australian Federal government’s Department of Health, Disability and Aged Care and the Medical Research Future Fund, CUREator+ supports the development and commercialisation of medical … Continued

LTR Pharma (ASX:LTP) Secures Stake in LevOmega to Advance Sustainable Omega-3 Innovation

By API User

22 September 2025 | Sydney, Australia – LTR Pharma Limited (ASX:LTP), a clinical-stage pharmaceutical company focused on rapid-acting intranasal therapies, is pleased to announce that it has secured a 33% equity stake in LevOmega Pty Ltd at no cost to shareholders. This investment provides LTR Pharma with new exposure to the global multi-billion-dollar omega-3 market, … Continued

EcoPHA welcomes Federal Government’s $1.1 billion Cleaner Fuels Program and announces world-first dual production of biofuels and bioplastics from Pongamia oils.

By API User

Key Facts: Federal Government launches $1.1 billion ten-year Cleaner Fuels Program to boost low-carbon liquid fuel production in Australia EcoPHA developing world's first integrated process to produce both renewable biofuels and marine-biodegradable bioplastics from Pongamia oil Project could contribute $1 billion to national economy and create thousands of regional jobs across plantations, refining and product … Continued

BlinkLab Onboards Vanderbilt Kennedy Center as Seventh U.S. Site for FDA 510(k) Autism Diagnostic Trial

By API User

Perth, Australia – 18 September 2025 | BlinkLab Limited (ASX:BB1), a leading digital health company developing AI-powered smartphone-based diagnostic tools, has today announced that it has engaged The Vanderbilt Kennedy Center in Nashville, Tennessee as its seventh U.S. clinical research site for its ongoing pivotal FDA 510(k) diagnostic trial aimed at autism. Seventh U.S. clinical … Continued

OncoSil Medical (ASX:OSL) Positive Preliminary Results from the PANCOSIL Phase 1-2 Study

By API User

Key Highlights: PANCOSIL is the first in the world study administering OncoSil™ via direct injection through the skin (percutaneous) under CT-imaging guidance for treatment of locally advanced pancreatic cancer (LAPC) Preliminary results from the PANCOSIL Investigator Initiated Study presented at the CIRSE 2025 Congress demonstrate it is both safe and feasible to deliver OncoSil™ by … Continued

BlinkLab (ASX:BB1) Engages University of Missouri’s Thompson Center as Sixth Clinical Site for U.S. FDA Diagnostic Trial

By API User

Perth, Australia – 17 September 2025 | BlinkLab Limited (ASX:BB1), a digital health company developing smartphone-based diagnostic tools for neurodevelopmental conditions, has today announced a further expansion of its U.S. clinical trial site network with the engagement of the Thompson Center for Autism & Neurodevelopment at the University of Missouri. The Center will assist in … Continued

4DMedical (ASX:4DX) 4DX signs agreements with national lung screening sites

By API User

Highlights • In collaboration with a leading global pharmaceutical company, 4DMedical launches a lung health screening program in Brazil, focusing on lung cancer screening and detecting incidental findings like coronary artery calcification and COPD • Royal Melbourne Hospital will pilot 4DMedical’s full portfolio for advanced lung ventilation analysis and clinical imaging assessment of lung health • … Continued

4DMedical (ASX:4DX) ASX CEO Expert Interview: World first breaking news

By API User

4DMedical gains U.S. CMS reimbursement for CT:VQ™ Highlights  U.S. Centers for Medicare & Medicaid Services (CMS) confirm reimbursement for CT:VQ™, accelerating the path to broad market adoption  CT:VQ™ will be reimbursed as a New Technology Ambulatory Payment Classification (APC) at US$650.50 per scan under the Hospital Outpatient Prospective Payment System (OPPS)  CMS will pay the … Continued

CUREator BioTech Incubator Grants $1.23M Top-Up Funding to High-Performing Participants

By API User

Melbourne, Australia, 4 September 2025 – CUREator, the Brandon BioCatalyst biotech Incubator, today announced $1.23 million in top-up funding for six high-performing participants from their Preclinical and Minimising Antimicrobial Resistance Streams. CUREator top-up funding was awarded through a competitive process by each stream’s Investment Review Committee, based on the progress made with initial project funding … Continued